This page captures some of the key outputs from the Network.

For more publications from the Hubs and further papers on methodology see here


TitleFirst authorReference
How individual participant data meta-analyses have influenced trial design, conduct, and analysisJayne Tierney et al[[|Journal of Clinical Epidemiology 2015]]
Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive studyClaire Vale et al[[|BMJ 2015]]
Surgical trials in head and neck oncology: Renaissance and revolution?Richard Shaw et al[[|Head & Neck 2015]]
Good Practice Principles for Sharing Individual Participant Data from Publicly Funded Clinical TrialsCatrin Tudur Smith et al [[|HTMR Network 2015]]
Interventions to improve recruitment and retention in clinical trials: a survey and workshop to assess current practice and future priorities.Peter Bower et al[[|Trials 20149]]
Adaptive designs for clinical trials assessing biomarker-guided treatment strategies.James Wason et al[[|British Journal of Cancer 2014 ]]
Risk-proportionate clinical trial monitoring: an example approach from a non-commercial trials unit.Catrin Tudur Smith et al [[|Trials 2014 ]]
Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials.Kerry Dwan et al[[|PLoS Med 2014]]
Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards.Michael Brundage et al[[|Qual Life Res. 2013]]
Can a core outcome set improve the quality of systematic reviews?--a survey of the Co-ordinating Editors of Cochrane Review Groups.Jamie J Kirkham et al[[|Trials. 2013]]
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.Melanie Calvert et al [[|JAMA. 2013 ]]
Principles of dose finding studies in cancer: a comparison of trial designs.Thomas Jaki et al[[|Cancer Chemother Pharmacol. 2013]]
Developing complex interventions for nursing: a critical review of key guidelines.Margarita Corry et al[[|J Clin Nurs. 2013]]
The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials.Ashley P Jones et al[[|BMC Med Res Methodol. 2013 ]]
Adaptive designs for dual-agent phase I dose-escalation studies.Jennifer A Harrington et al[[|Nat Rev Clin Oncol. 2013 ]]
Patient reported outcomes (PROs) in clinical trials: is 'in-trial' guidance lacking? a systematic review.Derek G Kyte et al[[|PLoS One. 20131]]
Evidence synthesis for decision making 7: a reviewer's checklist.Anthony E Ades et al [[|Med Decis Making. 2013 ]]
Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials.Sofia Dias et al[[|Med Decis Making. 2013 ]]
Resource-use measurement based on patient recall: issues and challenges for economic evaluation.Joanna C Thorn et al[[|Appl Health Econ Health Policy. 2013]]
Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review.Kerry Dwan et al[[|PLoS One. 2013 ]]
bcrm: Bayesian Continual Reassessment Method Designs for Phase I Dose Finding TrialsMichael Sweeting et al[[|J.Stat Software 2013]]
Planning multi-arm screening studies within the context of a drug development program.James Wason et al[[|Stat Med. 2013]]
Some recommendations for multi-arm multi-stage trials.James Wason et al[[|Stat Methods Med Res. 2013]]
The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice.Melanie Calvert et al[[|Health Qual Life Outcomes. 2013]]
Central statistical monitoring in multicentre clinical trials: developing statistical approaches for analysing key risk indicatorsJemma C Hopewell et al[[|Trials 2013 ]]
Driving up the quality and relevance of research through the use of agreed core outcomes.Paula Williamson et al[[|J Health Serv Res Policy. 2012 ]]
Recruiting patients into randomized clinical trials in surgery (W C H Jacobs et al[[|Br J Surg 2012]]
Optimal design of multi-arm multi-stage trials.James M S Wason et al[[|Stat Med. 2012 ]]
Developing core outcome sets for clinical trials: issues to consider.Paula Williamson et al[[|Trials. 2012]]
Standard 1: consent and recruitment.Patrina H Y Caldwell et al[[|Paediatrics 2012]]
Recruiting patients into randomized clinical trials in surgery.Jane M Blazeby[[|Br J Surg. 2012]]
Interventions to improve the use of systematic reviews in decision-making by health system managers, policy makers and clinicians.Lakshmi Murthy et al[[|Cochrane Library 2012]]
The value of source data verification in a cancer clinical trial.Catrin Tudur Smith et al [[|PLoS One. 2012 ]]
Development of a database of instruments for resource-use measurement: purpose, feasibility, and design.Colin H Ridyard et al[[|Value Health. 2012 ]]
Indirect and mixed treatment comparisons in arthritis research.Anthony E Ades et al [[|Rheumatology. 2011]]
Are head-to-head trials of biologics needed? The role of value of information methods in arthritis research.Nicky J Welton et al[[|Rheumatology 2011]]
An overview of models used in economic analyses of biologic therapies for arthritis--from current diversity to future consensus.Jason Madan et al[[|Rheumatology 2011]]
Effectiveness of biologics in rheumatology: improving the evidence base.Alan J Silman et al[[|Rheumatology 2011]]
Reporting quality of life in clinical trials: a CONSORT extension.Melanie Calvert et al[[|Lancet. 2011 ]]
A key risk indicator approach to central statistical monitoring in multicentre clinical trials: method development in the context of an ongoing large-scale randomized trialJemma Hopewell et al [[ |Trials 2011]]
Methods for the collection of resource use data within clinical trials: a systematic review of studies funded by the UK Health Technology Assessment program.Colin H Ridyard et al[[|Value in Health 2010]]
TitleFirst authorReference